Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin heavy chain 16 pseudogene (ENSG00000293559) is a genomic DNA sequence that closely resembles the functional myosin heavy chain 16 gene but does not encode a functional protein product, owing to mutations or sequence disruptions that have rendered it nonfunctional. Like other pseudogenes, it is considered a remnant of evolutionary processes, and while some pseudogenes can produce noncoding RNAs with potential regulatory roles, there is no evidence that this specific pseudogene has biological or disease relevance, nor is it considered a therapeutic target[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin heavy chain 16 pseudogene.